CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• EPS Cop. Y/Y Annual
Laboratory Corporation Of America Holdings  (LH)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

LH's EPS from Cont. Operations Growth by Quarter and Year

Laboratory Of America Holdings's EPS from Cont. Operations results by quarter and year




LH EPS from Cont. Operations (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -13.07 -18.78 -6.33
III Quarter September - 3.91 6.10 7.22
II Quarter June - 3.89 4.80 2.38
I Quarter March 2.41 5.27 7.88 -3.27
FY   2.41 0.00 0.00 0.00



LH EPS from Cont. Operations first quarter 2023 Y/Y Growth Comment
Laboratory Corporation Of America Holdings reported drop in EPS from Cont. Operations in the first quarter 2023 by -54.27% to $ 2.41 , from the same quarter in 2022.
The fall in the first quarter 2023 Laboratory Corporation Of America Holdings's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations doubling of 254.39%.

Looking into first quarter 2023 results within Medical Laboratories industry 8 other companies have achieved higher EPS from Cont. Operations growth. While Laboratory Corporation Of America Holdings' s EPS from Cont. Operations meltdown of -54.27% ranks overall at the positon no. 1481 in the first quarter 2023.


LH EPS from Cont. Operations ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - -35.9 % -15.51 % 219.47 %
II Quarter June - -18.96 % 101.68 % 22.68 %
I Quarter March -54.27 % -33.12 % - -
FY   - - - -

Financial Statements
Laboratory Of America Holdings's first quarter 2023 EPS from Cont. Operations $ 2.41 LH's Income Statement
Laboratory Of America Holdings's first quarter 2022 EPS from Cont. Operations $ 5.27 Quarterly LH's Income Statement
New: More LH's historic EPS from Cont. Operations Growth >>


LH EPS from Cont. Operations (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - -
III Quarter September - 0.51 % 27.08 % 203.36 %
II Quarter June - -26.19 % -39.09 % -
I Quarter March - - - -
FY (Year on Year)   - - - -


Go to LH financial reports >> Back to LH Growth rate Comparisons >>


EPS from Cont. Operations first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #101
Overall #1481

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
15700 % 254.39 % -99.25 %
(Mar 31 2016)   (Mar 31 2015)
EPS from Cont. Operations first quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #9
Healthcare Sector #101
Overall #1481
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
15700 % 254.39 % -99.25 %
(Mar 31 2016)   (Mar 31 2015)

EPS from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Laboratory Of America Holdings's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LH's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2023Seasonal Laboratory Corporation Of America Holdings in the circumstances EPS loss from Cont. Operations of $ 2.41 Seasonal circumstances appear to have led to Laboratory Corporation Of America Holdings's return to recovery, as LH clinchesEPS from Cont. Operations of $ 2.41 in the I. Quarter 2023 coming of EPS loss from Cont. Operations-13.07 in the fourth quarter. Laboratory Corporation Of America Holdings announced in the I. Quarter 2023 EPS from Cont. Operations of $ 2.41 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Medical Laboratories industry Laboratory Corporation Of America Holdings achieved highest sequential EPS from Cont. Operations growth. While Laboratory Of America Holdings's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LH's I. Quarter Q/Q EPS from Cont. Operations Comment
I. Quarter 2023Cyclical Laboratory Corporation Of America Holdings in the circumstances EPS loss from Cont. Operations of $ 2.41 Cyclical circumstances appear to have contributed Laboratory Corporation Of America Holdings's return to recovery, as LH clinchesEPS from Cont. Operations of $ 2.41 in the I. Quarter 2023 emanate EPS loss from Cont. Operations-13.07 in the fourth quarter. Laboratory Corporation Of America Holdings announced in the I. Quarter 2023 EPS from Cont. Operations of $ 2.41 compare to EPS loss from Cont. Operations recorded in previos quarter.

Within Medical Laboratories industry Laboratory Corporation Of America Holdings achieved highest sequential EPS from Cont. Operations growth. While Laboratory Of America Holdings's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Laboratory Of America Holdings's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)		 12 Months Ending
(Mar 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative EPS from Cont. Operations 12 Months Ending $ 0.00 $ -5.71 $ -3.52 $ -2.61 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #

New: More LH's historic EPS from Cont. Operations Growth >>



Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2022 period, Laboratory Of America Holdings's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

Laboratory Corporation Of America Holdings achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
In the Dec 31 2022 period, Laboratory Of America Holdings's cumulative trailing twelve month EPS from Cont. Operations remained unchanged compare to the same period a year ago.

Laboratory Corporation Of America Holdings achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Medical Laboratories Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
LH's EPS from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for LH's Competitors
EPS from Cont. Operations Growth for Laboratory Of America Holdings's Suppliers
EPS from Cont. Operations Growth for LH's Customers

You may also want to know
LH's Annual Growth Rates LH's Profitability Ratios LH's Asset Turnover Ratio LH's Dividend Growth
LH's Roe LH's Valuation Ratios LH's Financial Strength Ratios LH's Dividend Payout Ratio
LH's Roa LH's Inventory Turnover Ratio LH's Growth Rates LH's Dividend Comparisons



Companies with similar EPS from Cont. Operations meltdown for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2023
Intuitive Surgical Inc -0.98%$ -0.980 
United Therapeutics Corporation-2.07%$ -2.072 
Lemaitre Vascular Inc -3.57%$ -3.571 
Zoetis Inc -5.56%$ -5.556 
Edwards Lifesciences Corporation-6.67%$ -6.667 
Iqvia Holdings Inc -8.77%$ -8.772 
Vertex Pharmaceuticals Inc-9.03%$ -9.030 
Lifevantage Corp-11.11%$ -11.111 
U S Physical Therapy Inc-13.43%$ -13.433 
Insulet Corporation-15.00%$ -15.000 
Chemed Corporation-15.42%$ -15.421 
Regeneron Pharmaceuticals Inc -16.23%$ -16.228 
National Research Corporation-17.65%$ -17.647 
Amedisys Inc-19.59%$ -19.588 
West Pharmaceutical Services Inc -19.66%$ -19.658 
3m Company-22.03%$ -22.026 
Integra Lifesciences Holdings Corp-23.08%$ -23.077 
National Healthcare Corp-23.23%$ -23.232 
Davita Inc -23.81%$ -23.810 
American Shared Hospital Services-25.00%$ -25.000 
Biomx Inc -25.93%$ -25.926 
Central Garden and Pet Company-29.23%$ -29.231 
Eli Lilly And Company-29.38%$ -29.384 
Corcept Therapeutics Inc-31.82%$ -31.818 
Align Technology inc -33.33%$ -33.333 
Halozyme Therapeutics Inc -34.09%$ -34.091 
Supernus Pharmaceuticals inc -35.42%$ -35.417 
Baxter International Inc -35.71%$ -35.714 
Avantor Inc -37.93%$ -37.931 
Repligen Corp-38.82%$ -38.824 


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071